Exacerbation of glycoprotein VI-dependent platelet responses in a rhesus monkey model of type 1 diabetes

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Arthur, J F ^a   Shen, Y ^a   Chen, Y ^b   Qiao, J ^a   Ni, R ^b   Lu, Y ^b   Andrews, R K ^a   Gardiner, E E ^a   Cheng, J ^b  

^a MONASH UNIVERSITY   (Australia)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAY 613606; GLUCOSE; GLYCOPROTEIN VI; PROTEIN KINASE SYK; PROTEIN KINASE SYK INHIBITOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 2-(7-(3,4-DIMETHOXYPHENYL)IMIDAZO(1,2-C)PYRIMIDIN-5-YLAMINO)NICOTINAMIDE; CALCIUM; FIBRINOGEN RECEPTOR; NICOTINAMIDE; PLATELET MEMBRANE GLYCOPROTEIN VI; PYRIMIDINE DERIVATIVE; 2 (7 (3,4 DIMETHOXYPHENYL)IMIDAZO(1,2 C)PYRIMIDIN 5 YLAMINO)NICOTINAMIDE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; ANALOGS AND DERIVATIVES; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; FEMALE; MALE; METABOLISM; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; MACACA MULATTA; MALE; NIACINAMIDE; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; PYRIMIDINES; REACTIVE OXYGEN SPECIES;

EID: 84879406310     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/370212     Document Type: Article

References (43)

1. Daneman D., Type 1 diabetes. The Lancet 2006 367 9513 847 858 2-s2.0-33644841145 10.1016/S0140-6736(06)68341-4 (Pubitemid 43363372)
2. Serebruany V., Pokov I., Kuliczkowski W., Chesebro J., Badimon J., Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thrombosis and Haemostasis 2008 100 1 76 82 2-s2.0-46749087824 10.1160/TH08-03-0136 (Pubitemid 351948748)
3. Ferreiro J. L., Gomez-Hospital J. A., Angiolillo D. J., Platelet abnormalities in diabetes mellitus. Diabetes and Vascular Disease Research 2010 7 4 251 259 10.1177/1479164110383994
4. Carr M. E., Diabetes mellitus: a hypercoagulable state. Journal of Diabetes and Its Complications 2001 15 1 44 54 2-s2.0-0035093810 10.1016/S1056-8727(00)00132-X (Pubitemid 32203891)
5. Antithrombotic Trialists' Collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal 2002 324 7329 71 86 2-s2.0-0037065502
6. Hansson L., Zanchetti A., Carruthers S. G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K. H., Wedel H., Westerling S., Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. The Lancet 1998 351 9118 1755 1762 10.1016/S0140-6736(98)04311- 6 (Pubitemid 28269185)
7. Tocci G., Ferrucci A., Guida P., Avogaro A., Comaschi M., Corsini A., Cortese C., Giorda C. B., Manzato E., Medea G., Mureddu G. F., Riccardi G., Titta G., Ventriglia G., Zito G. B., Volpe M., Impact of diabetes mellitus on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) educational program. Clinical Cardiology 2011 34 9 560 566 2-s2.0-80052695290 10.1002/clc.20937
8. Arthur J. F., Shen Y., Gardiner E. E., Coleman L., Kenny D., Andrews R. K., Berndt M. C., TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. Journal of Thrombosis and Haemostasis 2011 9 1 163 172 2-s2.0-78650931856 10.1111/j.1538-7836.2010.04091.x
9. Arthur J. F., Qiao J., Shen Y., Davis A. K., Dunne E., Berndt M. C., Gardiner E. E., Andrews R. K., ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. Journal of Thrombosis and Haemostasis 2012 10 6 1133 1141 10.1111/j.1538-7836.2012.04734.x
10. Qiao J. L., Shen Y., Gardiner E. E., Andrews R. K., Proteolysis of platelet receptors in humans and other species. Biological Chemistry 2010 391 8 893 900 2-s2.0-77955947692 10.1515/BC.2010.081
11. Gardiner E. E., Karunakaran D., Shen Y., Arthur J. F., Andrews R. K., Berndt M. C., Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. Journal of Thrombosis and Haemostasis 2007 5 7 1530 1537 2-s2.0-34250753264 10.1111/j.1538-7836.2007.02590.x (Pubitemid 46965384)
12. Gardiner E. E., Arthur J. F., Kahn M. L., Berndt M. C., Andrews R. K., Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 2004 104 12 3611 3617 2-s2.0-7044232239 10.1182/blood-2004-04-1549 (Pubitemid 39564435)
13. Jin X., Zeng L., Rong S., Comparison of single high-dose STZ with partial pancreatectomy combined with low-dose STZ for diabetes induction in rhesus monkeys. Experimental Biology and Medicine 2010 235 877 885
14. Qiao C. F., Tian B. L., Mai G., Wei L. L., Jin X., Ren Y., Chen Y. N., Li H. X., Li Y. P., Wang L., Cheng J. Q., Lu Y. R., Induction of diabetes in rhesus monkeys and establishment of insulin administration strategy. Transplantation Proceedings 2009 41 1 413 417 2-s2.0-60649084226 10.1016/j.transproceed.2008.08.144
15. Bakdash N., Williams M. S., Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radical Biology and Medicine 2008 45 2 158 166 2-s2.0-44649152906 10.1016/j.freeradbiomed.2008.03.021
16. Begonja A. J., Gambaryan S., Geiger J. R., Aktas B., Pozgajova M., Nieswandt B., Walter U., Platelet NAD(P)H-oxidase-generated ROS production regulates α IIb β 3-integrin activation independent of the NO/cGMP pathway. Blood 2005 106 8 2757 2760 2-s2.0-27144548487 10.1182/blood-2005-03- 1047 (Pubitemid 41510751)
17. 2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochemical and Biophysical Research Communications 2005 333 3 794 802 2-s2.0-20744456318 10.1016/j.bbrc.2005.05.178 (Pubitemid 40854229)
18. Jennings L. K., Dockter M. E., Wall C. D., Fox C. F., Kennedy D. M., Calcium mobilization in human platelets using indo-1 and flow cytometry. Blood 1989 74 8 2674 2680 2-s2.0-0024316819 (Pubitemid 20007791)
19. Monteiro M. D., Goncalves M. J., Sansonetty F., O'Connor J. E., Flow cytometric analysis of calcium mobilization in whole-blood platelets. Current Protocols in Cytometry 2003 chapter 9:unit 9.20 10.1002/0471142956.cy0920s24
20. Al-Tamimi M., Mu F., Arthur J. F., Shen Y., Moroi M., Berndt M. C., Andrews R. K., Gardiner E. E., Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of Fc γ RIIa and induce GPVI ectodomain shedding. Platelets 2009 20 2 75 82 2-s2.0-61649117544 10.1080/09537100802645029
21. Gardiner E. E., Karunakaran D., Arthur J. F., Mu F., Powell M. S., Baker R. I., Hogarth P. M., Kahn M. L., Andrews R. K., Berndt M. C., Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-izing Fc γ RIIa. Blood 2008 111 1 165 174 2-s2.0-38049187115 10.1182/blood-2007-04-086983
22. Shen Y., Romo G. M., Dong J., Schade A., McIntire L. V., Kenny D., Whisstock J. C., Berndt M. C., López J. A., Andrews R. K., Requirement of leucine-rich repeats of glycoprotein (GP) Ib α for shear- dependent and static binding of von willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood 2000 95 3 903 910 2-s2.0-12944317287 (Pubitemid 30062712)
23. Barsam S. J., Psaila B., Forestier M., Page L. K., Sloane P. A., Geyer J. T., Villarica G. O., Ruisi M. M., Gernsheimer T. B., Beer J. H., Bussel J. B., Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 2011 117 21 5723 5732 2-s2.0-79957616016 10.1182/blood-2010-11-321398
24. Yamamoto N., Takeshita K., Shichijo M., Kokubo T., Sato M., Nakashima K., Ishimori M., Nagai H., Li Y., Yura T., Bacon K. B., The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5- ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. Journal of Pharmacology and Experimental Therapeutics 2003 306 3 1174 1181 2-s2.0-0041932075 10.1124/jpet.103.052316 (Pubitemid 37025329)
25. Best D., Senis Y. A., Jarvis G. E., Eagleton H. J., Roberts D. J., Saito T., Jung S. M., Moroi M., Harrison P., Green F. R., Watson S. P., GPVI levels in platelets: relationship to platelet function at high shear. Blood 2003 102 8 2811 2818 2-s2.0-0141923911 10.1182/blood-2003-01-0231 (Pubitemid 37248851)
26. Chen H., Locke D., Liu Y., Liu C., Kahn M. L., The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. Journal of Biological Chemistry 2002 277 4 3011 3019 2-s2.0-0037169552 10.1074/jbc.M109714200 (Pubitemid 34953338)
27. Leoncini G., Signorello M. G., Piana A., Carrubba M., Armani U., Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. Thrombosis Research 1997 86 2 153 160 2-s2.0-0030986035 10.1016/S0049-3848(97)00058-3 (Pubitemid 27235127)
28. Lawson M. L., Gerstein H. C., Tsui E., Zinman B., Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care 1999 22 2 B35 B39 2-s2.0-0032972729 (Pubitemid 29107146)
29. Roshan B., Tofler G. H., Weinrauch L. A., Gleason R. E., Keough J. A., Lipinska I., Lee A. T., D'Elia J. A., Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease. Metabolism 2000 49 1 88 91 2-s2.0-0033957937 (Pubitemid 30054038)
30. Davi G., Averna M., Catalano I., Barbagallo C. M., Giovenco E., Carroccio A., Notarbartolo A., Strano A., Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control. Diabetes Research 1989 10 1 7 12 2-s2.0-0024338502 (Pubitemid 19152892)
31. Rowe P. A., Kavanagh K., Zhang L., Harwood H. J. Jr., Wagner J. D., Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys. Metabolism 2011 60 8 1070 1080 2-s2.0-79960559558 10.1016/j.metabol.2010.11.003
32. Westerbacka J., Yki-Järvinen H., Turpeinen A., Rissanen A., Vehkavaara S., Syrjälä M., Lassila R., Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 1 167 172 2-s2.0-0036144715 10.1161/hq0102.101546 (Pubitemid 34076249)
33. Rauchfuss S., Geiger J., Walter U., Renne T., Gambaryan S., Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets. Journal of Thrombosis and Haemostasis 2008 6 5 856 864 2-s2.0-42149148643 10.1111/j.1538-7836.2008. 02925.x (Pubitemid 351524548)
34. Akkerman J. W., Gerrits A. J., Ferreira I. A., Heemskerk J. W. M., Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets: a rebuttal. Journal of Thrombosis and Haemostasis 2009 7 2 369 371 2-s2.0-59049094027 10.1111/j.1538-7836.2008.03239.x
35. Jindal S., Gupta S., Gupta R., Kakkar A., Singh H. V., Gupta K., Singh S., Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology 2011 16 2 86 89 2-s2.0-79952638914 10.1179/102453311X12902908412110
36. Watala C., Boncler M., Pietrucha T., Trojanowski Z., Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity? Platelets 1999 10 1 52 60 2-s2.0-0033045148 10.1080/09537109976356 (Pubitemid 29084386)
37. Cabeza N., Li Z., Schulz C., Kremmer E., Massberg S., Bültmann A., Gawaz M., Surface expression of collagen receptor Fc receptor- γ /glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 2004 53 8 2117 2121 2-s2.0-3242780114 10.2337/diabetes.53.8.2117 (Pubitemid 38970763)
38. Takaya J., Iwamoto Y., Higashino H., Ishihara R., Kobayashi Y., Increased intracellular calcium and altered phorbol dibutyrate binding to intact platelets in young subjects with insulin-dependent and non-insulin- dependent diabetes mellitus. Metabolism 1997 46 8 949 953 2-s2.0-0030755440 10.1016/S0026-0495(97)90085-8 (Pubitemid 27339922)
39. Jardín I., Redondo P. C., Salido G. M., Pariente J. A., Rosado J. A., Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus. Platelets 2006 17 5 283 288 2-s2.0-33747803057 10.1080/09537100600745187 (Pubitemid 44277692)
40. Andre P., Morooka T., Sim D., Abe K., Lowell C., Nanda N., Delaney S., Siu G., Yan Y., Hollenbach S., Pandey A., Gao H., Wang Y., Nakajima K., Parikh S. A., Shi C., Phillips D., Owen W., Sinha U., Simon D. I., Critical role for Syk in responses to vascular injury. Blood 2011 118 18 5000 5010 2-s2.0-80855144790 10.1182/blood-2011-06-360743
41. Colonna L., Catalano G., Chew C., D'Agati V., Thomas J. W., Wong F. S., Schmitz J., Masuda E. S., Reizis B., Tarakhovsky A., Clynes R., Therapeutic targeting of Syk in autoimmune diabetes. Journal of Immunology 2010 185 3 1532 1543 2-s2.0-77956417942 10.4049/jimmunol.1000983
42. Schulz C., Leuschen N. V., Fröhlich T., Lorenz M., Pfeiler S., Gleissner C. A., Kremmer E., Kessler M., Khandoga A. G., Engelmann B., Ley K., Massberg S., Arnold G. J., Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 2010 115 20 4102 4110 2-s2.0-77953242217 10.1182/blood-2009-07-230268
43. Tang W. H., Stitham J., Gleim S., Di Febbo C., Porreca E., Fava C., Tacconelli S., Capone M., Evangelista V., Levantesi G., Wen L., Martin K., Minuz P., Rade J., Patrignani P., Hwa J., Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. Journal of Clinical Investigation 2011 121 11 4462 4476 2-s2.0-80555148930 10.1172/JCI59291